Free Trial

Bluejay Diagnostics (BJDX) Short Interest Ratio & Short Volume

Bluejay Diagnostics logo
$1.98 -0.23 (-10.41%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.96 -0.02 (-1.26%)
As of 04/17/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bluejay Diagnostics Short Interest Data

Bluejay Diagnostics (BJDX) has a short interest of 22,800 shares, representing 4.13% of the float (the number of shares available for trading by the public). This marks a 280.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 464,451 shares to cover all short positions.

Current Short Interest
22,800 shares
Previous Short Interest
6,000 shares
Change Vs. Previous Month
+280.00%
Dollar Volume Sold Short
$85,044.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
554,000 shares
Float Size
552,400 shares
Short Percent of Float
4.13%
Today's Trading Volume
203,726 shares
Average Trading Volume
464,451 shares
Today's Volume Vs. Average
44%
Short Selling Bluejay Diagnostics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bluejay Diagnostics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BJDX Short Interest Over Time

BJDX Days to Cover Over Time

BJDX Percentage of Float Shorted Over Time

Bluejay Diagnostics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202522,800 shares $85,044.00 +280.0%4.1%0 $3.73
3/15/20256,000 shares $24,240.00 -80.0%1.1%0.1 $4.04
2/28/202530,000 shares $128,400.00 +98.7%5.4%0.1 $4.28
2/15/202515,100 shares $53,529.50 +4.9%2.7%0 $3.55
1/31/202514,400 shares $52,992.00 +5.1%2.6%0 $3.68
1/15/202513,700 shares $47,539.00 +3.0%2.5%0 $3.47
12/31/202413,300 shares $64,771.00 -50.9%2.4%0 $4.87
12/15/202427,100 shares $125,473.00 +298.5%4.9%0 $4.63
11/30/20246,800 shares $23,800.00 -40.4%1.2%0 $3.50
11/15/202411,400 shares $37,734.00 -46.0%2.1%0 $3.31
10/31/202421,100 shares $1,825.15 -86.8%0.1%0 $0.09
10/15/2024159,900 shares $17,509.05 +300.8%1.0%0.1 $0.11
9/30/202439,900 shares $5,067.30 -59.2%0.2%0 $0.13
9/15/202497,700 shares $14,782.01 -9.4%0.6%0 $0.15
8/31/2024107,800 shares $20,126.26 -35.0%2.0%0.1 $0.19
8/15/2024165,800 shares $50,734.80 +523.3%3.1%0.1 $0.31
7/31/202426,600 shares $12,775.98 -29.4%5.5%0 $0.48
7/15/202437,700 shares $21,602.10 -82.9%7.8%0.1 $0.57
6/30/2024220,500 shares $154,173.60 +1,370.0%43.5%0.8 $0.70
6/15/202415,000 shares $61,200.00 -23.1%3.2%0.3 $4.08
5/31/202419,500 shares $10,335.00 +191.0%0.8%0.1 $0.53
5/15/20246,700 shares $3,517.50 -89.9%0.3%0.1 $0.53
4/30/202466,100 shares $32,389.00 +16,425.0%3.9%1.2 $0.49
4/15/2024400 shares $248.00 -96.4%0.0%0 $0.62
3/31/202411,000 shares $8,830.80 -50.0%0.7%0.2 $0.80
3/15/202422,000 shares $17,604.40 -10.6%0.1%0.3 $0.80
2/29/202424,600 shares $18,942.00 +78.3%0.2%0.4 $0.77
2/15/202413,800 shares $10,902.00 -43.9%0.1%0.3 $0.79
1/31/202424,600 shares $19,692.30 -29.3%0.2%0.5 $0.80
1/15/202434,800 shares $35,496.00 -61.8%4.5%0.8 $1.02
12/31/202391,200 shares $111,264.00 +2,940.0%11.7%2.1 $1.22
12/15/20233,000 shares $8,730.00 -26.8%0.4%0.1 $2.91
11/30/20234,100 shares $13,243.00 +28.1%0.5%0 $3.23
11/15/20233,200 shares $10,880.00 -54.3%0.4%0 $3.40
10/31/20237,000 shares $24,220.00 -66.2%0.9%0 $3.46
10/15/202320,700 shares $80,523.00 -43.1%2.6%0 $3.89
9/30/202336,400 shares $157,612.00 +766.7%4.6%0 $4.33
9/15/20234,200 shares $12,852.00 -93.4%0.5%0 $3.06
8/31/202363,300 shares $370,938.00 -22.9%9.2%0.1 $5.86
8/15/202382,100 shares $620,676.00 -5.7%14.4%0.1 $7.56
Trump’s Top Secret $9 Trillion AI Superweapon (Ad)

Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that could benefit.

Nvidia’s early days made millionaires. This AI play might too.
7/31/202387,100 shares $557,440.00 +53.6%15.3%0.1 $6.40
7/15/202356,700 shares $298,468.80 -76.2%10.0%0.3 $5.26
6/30/2023238,200 shares $64,218.72 -19.9%2.1%0.2 $0.27
6/15/2023297,200 shares $66,572.80 +134.4%2.6%0.6 $0.22
5/31/2023126,800 shares $29,962.84 +328.4%1.3%0.3 $0.24
5/15/202329,600 shares $8,290.96 +15.2%0.3%0.3 $0.28
4/30/202325,700 shares $7,681.73 -52.2%0.3%0.2 $0.30
4/15/202353,800 shares $19,653.14 +77.6%0.6%0.5 $0.37
3/31/202330,300 shares $12,398.76 -46.7%0.3%0.3 $0.41
3/15/202356,800 shares $30,672.00 -0.5%0.6%0.5 $0.54
2/28/202357,100 shares $37,997.20 -49.6%0.6%0.5 $0.67
2/15/2023113,300 shares $90,640.00 +192.8%1.2%1 $0.80
1/31/202338,700 shares $16,590.69 -21.7%0.4%0.4 $0.43
1/15/202349,400 shares $25,189.06 -14.1%0.5%0.9 $0.51
12/30/202257,500 shares $21,844.19 -25.8%0.6%1 $0.38
12/15/202277,500 shares $33,332.75 -34.3%0.8%1.2 $0.43
11/30/2022118,000 shares $80,240.00 -0.1%1.2%1.7 $0.68
11/15/2022118,100 shares $85,539.83 -23.8%1.2%1.5 $0.72
10/31/2022154,900 shares $128,412.10 -18.6%1.5%2.1 $0.83
10/15/2022190,300 shares $155,094.50 -11.8%1.9%1.4 $0.82
9/30/2022215,700 shares $168,246.00 +337.5%2.2%1.4 $0.78
9/15/202249,300 shares $44,838.35 -37.8%0.5%0.3 $0.91
8/31/202279,300 shares $81,679.00 +48.5%0.8%0.1 $1.03
8/15/202253,400 shares $60,342.00 -77.3%0.5%0.1 $1.13
7/31/2022235,600 shares $266,228.00 +550.8%2.3%0.2 $1.13
7/15/202236,200 shares $42,716.00 -51.3%0.4%0 $1.18
6/30/202274,400 shares $78,120.00 -56.3%0.7%0.1 $1.05
6/15/2022170,300 shares $170,300.00 +45.1%1.7%0.2 $1.00
5/31/2022117,400 shares $125,618.00 -40.4%1.2%0.5 $1.07
5/15/2022197,100 shares $218,781.00 -15.2%2.0%0.7 $1.11
4/30/2022232,300 shares $271,791.00 +48.7%2.3%0.6 $1.17
4/15/2022156,200 shares $162,448.00 +66.5%1.6%0.3 $1.04
3/31/202293,800 shares $105,056.00 +5.5%1.0%0.1 $1.12
3/15/202288,900 shares $83,566.00 +46.0%0.9%0.1 $0.94
2/28/202260,900 shares $63,336.00 -60.1%0.6%0 $1.04
2/15/2022152,700 shares $175,605.00 -56.6%1.6%0.1 $1.15
1/31/2022351,600 shares $580,140.00 -60.8%3.7%0.2 $1.65
1/15/2022896,100 shares $2.38 million +80.2%N/A0.4 $2.66
12/31/2021497,400 shares $1.27 million No ChangeN/A0.2 $2.56

BJDX Short Interest - Frequently Asked Questions

What is Bluejay Diagnostics' current short interest?

Short interest is the volume of Bluejay Diagnostics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 22,800 shares of BJDX short. 4.13% of Bluejay Diagnostics' shares are currently sold short. Learn More on Bluejay Diagnostics' current short interest.

What is a good short interest percentage for Bluejay Diagnostics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.13% of Bluejay Diagnostics' floating shares are currently sold short.

Is Bluejay Diagnostics' short interest increasing or decreasing?

Bluejay Diagnostics saw a increase in short interest in March. As of March 31st, there was short interest totaling 22,800 shares, an increase of 280.0% from the previous total of 6,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bluejay Diagnostics' float size?

Bluejay Diagnostics currently has issued a total of 554,000 shares. Some of Bluejay Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bluejay Diagnostics currently has a public float of 552,400 shares.

How does Bluejay Diagnostics' short interest compare to its competitors?

4.13% of Bluejay Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Bluejay Diagnostics: Sintx Technologies, Inc. (3.97%), Autonomix Medical, Inc. (4.57%), Nuwellis, Inc. (3.80%), Check-Cap Ltd. (2.12%), Heart Test Laboratories, Inc. (3.11%), Quoin Pharmaceuticals, Ltd. (0.10%), Venus Concept Inc. (6.23%), Tivic Health Systems, Inc. (4.88%), Carmell Co. (0.60%), T2 Biosystems, Inc. (6.78%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Bluejay Diagnostics stock?

Short selling BJDX is an investing strategy that aims to generate trading profit from Bluejay Diagnostics as its price is falling. BJDX shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bluejay Diagnostics?

A short squeeze for Bluejay Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BJDX, which in turn drives the price of the stock up even further.

How often is Bluejay Diagnostics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BJDX, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:BJDX) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners